Journal
RESPIROLOGY
Volume 25, Issue 11, Pages 1123-1125Publisher
WILEY
DOI: 10.1111/resp.13926
Keywords
Anti-IL5 biologicals; eosinophils; severe asthma
Categories
Funding
- Frederick E. Hargreave Teva Innovation Chair in Airway Diseases